Achtung Grapefruit! In: Apotheke Adhoc, 13. August 2019; abgerufen am 27. Oktober 2020
asahq.org
pubs.asahq.org
Keith A. Candiotti et al.: The Impact of Pharmacogenomics on Postoperative Nausea and Vomiting: Do CYP2D6 Allele Copy Number and Polymorphisms Affect the Success or Failure of Ondansetron Prophylaxis? In: Anaesthesiology, März 2005, 102, 3, S. 543–549. pubs.asahq.org abgerufen am 13. November 2020
aspetjournals.org
dmd.aspetjournals.org
Shamema Nasrin, Christy J. W. Watson, Yadira X. Perez-Paramo, Philip Lazarus: Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. In: Drug Metabolism and Disposition. Band49, Nr.12, 1. Dezember 2021, ISSN0090-9556, S.1070–1080, doi:10.1124/dmd.121.000442, PMID 34493602 (aspetjournals.org [abgerufen am 11. Juni 2022]).
doi.org
F. P. Guengerich: Cytochrome P-450 3A4: regulation and role in drug metabolism. In: Annual review of pharmacology and toxicology, 1999, Band 39, S. 1–17, doi:10.1146/annurev.pharmtox.39.1.1, PMID 10331074.
H Hashimoto, K Toide, R Kitamura, M Fujita, S Tagawa, S Itoh, T Kamataki: Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. In: Eur. J. Biochem.Band218, Nr.2, Dezember 1993, S.585–595, doi:10.1111/j.1432-1033.1993.tb18412.x, PMID 8269949 (englisch).
K Inoue, J Inazawa, H Nakagawa, T Shimada, H Yamazaki, FP Guengerich, T Abe: Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization. In: Jpn. J. Hum. Genet. Band37, Nr.2, Juni 1992, S.133–138, doi:10.1007/BF01899734, PMID 1391968 (englisch).
Shamema Nasrin, Christy J. W. Watson, Yadira X. Perez-Paramo, Philip Lazarus: Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. In: Drug Metabolism and Disposition. Band49, Nr.12, 1. Dezember 2021, ISSN0090-9556, S.1070–1080, doi:10.1124/dmd.121.000442, PMID 34493602 (aspetjournals.org [abgerufen am 11. Juni 2022]).
F. P. Guengerich: Cytochrome P-450 3A4: regulation and role in drug metabolism. In: Annual review of pharmacology and toxicology, 1999, Band 39, S. 1–17, doi:10.1146/annurev.pharmtox.39.1.1, PMID 10331074.
H Hashimoto, K Toide, R Kitamura, M Fujita, S Tagawa, S Itoh, T Kamataki: Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. In: Eur. J. Biochem.Band218, Nr.2, Dezember 1993, S.585–595, doi:10.1111/j.1432-1033.1993.tb18412.x, PMID 8269949 (englisch).
K Inoue, J Inazawa, H Nakagawa, T Shimada, H Yamazaki, FP Guengerich, T Abe: Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization. In: Jpn. J. Hum. Genet. Band37, Nr.2, Juni 1992, S.133–138, doi:10.1007/BF01899734, PMID 1391968 (englisch).
Kaja M. Konieczny, Paul Dorian: Clinically Important Drug–Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants. In: Journal of Innovation in Cardiac Management, März 2019, 10, 3, S. 352–355. PMC 7252850 (freier Volltext).
Shamema Nasrin, Christy J. W. Watson, Yadira X. Perez-Paramo, Philip Lazarus: Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. In: Drug Metabolism and Disposition. Band49, Nr.12, 1. Dezember 2021, ISSN0090-9556, S.1070–1080, doi:10.1124/dmd.121.000442, PMID 34493602 (aspetjournals.org [abgerufen am 11. Juni 2022]).
Shamema Nasrin, Christy J. W. Watson, Yadira X. Perez-Paramo, Philip Lazarus: Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. In: Drug Metabolism and Disposition. Band49, Nr.12, 1. Dezember 2021, ISSN0090-9556, S.1070–1080, doi:10.1124/dmd.121.000442, PMID 34493602 (aspetjournals.org [abgerufen am 11. Juni 2022]).
